About us

We are My Shepherd Testing (MST) and our mission is to promote the health and well-being of both individuals and organizations by providing safer environments that empower our partners to achieve their greatest success. The COVID test we utilize is DiaCarta’s FDA approved RT-PCR test, the gold standard for the best accuracy.  Our services are made free by reimbursements from either the individual’s health insurance or the federal government’s CARES ACT.  MST provides medical assistants for on-site sample collection, ships samples to our partner high complexity CLIA lab for testing and delivers results electronically.  We understand waiting for results can be stressful and we strive to work quickly without sacrificing quality with results coming typically 24 hours after the lab receives the samples.  

MST is committed to charity and giving back to the communities we work with by donating 10% of our net proceeds to nonprofits.  When our partner organization is a nonprofit like a school or a church, we donate those proceeds back to the organization.

diacarta.jpg

We have partnered with DiaCarta Laboratory

DiaCarta is a molecular diagnostics company that has developed innovative technologies that transform patient care by providing effective precision diagnostics using liquid biopsy. In addition to its FDA EUA approved QuantiVirus SARS-CoV-2 Tests, DiaCarta offers a range of testing services, from single-gene QClamp qPR tests to its OptiSeq XNA-NGS panels. DiaCarta has developed and continues to develop and adapt to the changing COVID virus since the beginning of the pandemic. DiaCarta’s COVID test is the top 5 most sensitive test currently approved by the FDA and simultaneously identifies and differentiates all the new mutating COVID 19 variants including the Alpha (UK), Beta (S. Africa), Gamma (Brazil), Delta (India), Delta Plus (India), Epsilon (California) and the Kappa (India) variants.